共 18 条
[1]
BARNETT E, 1960, Clin Radiol, V11, P166, DOI 10.1016/S0009-9260(60)80012-8
[2]
Black DM, 1999, J BONE MINER RES, V14, pS252
[5]
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures - Results from the fracture intervention trial
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1998, 280 (24)
:2077-2082
[6]
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene -: Results from a 3-year randomized clinical trial
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1999, 282 (07)
:637-645
[8]
Hamdy Ronald C, 2002, J Clin Densitom, V5 Suppl, pS11, DOI 10.1385/JCD:5:3S:S11
[9]
Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis - A randomized controlled trial
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1999, 282 (14)
:1344-1352
[10]
HORSMAN A, 1975, BRIT J RADIOL, V48, P471, DOI 10.1259/0007-1285-48-570-470

